The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of sorafenib in patients with desmoid-type fibromatosis.
 
Rodrigo Ramella Munhoz
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Lilly
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Robert A Lefkowitz
No Relationships to Disclose
 
Deborah Kuk
No Relationships to Disclose
 
Mark Andrew Dickson
No Relationships to Disclose
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono
 
Mary Louise Keohan
No Relationships to Disclose
 
Ping Chi
No Relationships to Disclose
 
Aimee Marie Crago
No Relationships to Disclose
 
Robert G. Maki
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Janssen
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Epizyme (Inst); Immune Design (Inst); Lilly (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Janssen Oncology; TRACON Pharma
 
Gary K. Schwartz
Honoraria - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Novartis
 
Li-Xuan Qin
No Relationships to Disclose
 
William D. Tap
Consulting or Advisory Role - Advaxis; Ariad; Daiichi Sankyo; EMD Serono; Janssen; Lilly; Plexxikon
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - Morphotek
 
Mrinal M. Gounder
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Karyopharm Therapeutics
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo